Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy 2021-08-11 23:00
Dassiet and OrthoPets Collaborate to Provide Safer and Easier Orthopedic Care for Pets 2021-08-11 21:27
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director 2021-08-11 20:31
Sihuan Pharmaceutical (0460.HK): Say "No" to Smuggled Products - Advocate 'Positive Energy' of China's Medical Aesthetics Industry 2021-08-11 17:59
Invitation to the presentation of Elekta's first quarter 2021/22 2021-08-11 14:16
ImmVira's MVR-T3011 IV Completed First Dosing for Intravenous Administration in a U.S. Phase I Clinical Trial 2021-08-11 10:45
PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021 2021-08-11 09:00
Zuellig Pharma Singapore Named 'Industry Champions of the Year' at the Asia Corporate Excellence & Sustainability Awards 2021 2021-08-11 09:00
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP in China 2021-08-11 08:00
Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021 Exploring The Profiles Of Australian Contour®Diabetes App Users 2021-08-11 07:00
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China 2021-08-10 23:39
DERMALOG is one of Germany's most innovative SMEs 2021-08-10 22:17
Novaliq Completes Enrollment of Second Phase 3 Study for CyclASol® for the Treatment of Dry Eye Disease 2021-08-10 20:00
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with Its Systems Integration Solution 2021-08-10 20:00
Dymicron® Names Gunther Peeters as Senior Vice President of Commercial Operations 2021-08-10 14:17
Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine 2021-08-10 14:00
Australia's Cancer Organisations Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster' During Pandemic 2021-08-10 04:00
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas 2021-08-09 21:47
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand 2021-08-09 21:00
111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow 2021-08-09 19:30
1 357 358 359 360 361 892